Anti-PDCD1 monoclonal antibody, clone SNQ2-25 Functional Grade

Background: A genome-wide scan has suggested a strongly significant association between chromosome 2q37 gene loci and susceptibility to systemic lupus erythematosus (SLE) and just right the programmed cell death 1 (PDCD1) gene is located on chromosome 2q37, but there is no precise conclusion existing. Aim: To derive a more precise evaluation the association of PDCD1 gene single nuclear polymorphisms (SNPs) with susceptibility to SLE and lupus nephritis (LN) through meta-analysis. Methods: EMBASE and PubMed were exhaustively searched for studies up to September 2015. Begg's funnel plot and Egger's test were performed to assess the publication bias of the literature, and sensitivity analyses were performed to identify heterogeneity. A fixed- or a random-effects model was applied to calculate the pooled odds ratio (OR). Results: The results of the pooled analysis suggested that PD1.3 SNPs were significantly associated with the risk of SLE. When the studies were stratified by ethnicity, a significant association between PD1.3A/G and SLE was observed in Latin [OR=2.961, 95% CI=1.776-4.936, P<0.001], but not in Caucasian, African and Asian populations. The PD1.3A allele was a risk factor for LN both in overall and Caucasian descendants [overall: OR=1.776, 95% CI=1.290-2.444, P<0.001; Caucasian: OR=1.873, 95% CI=1.341-2.616, P<0.001]. Whereas, no significant associations were found between PD1.1, PD1.5 or PD1.6 SNPs and SLE. Conclusions: PD1.3A allele is associated with susceptibility to SLE and LN. However, more well-designed studies with large sample size are needed to validate this association.

Immune selection drives tumor cells to acquire refractory phenotypes. We previously demonstrated that cytotoxic T lymphocyte (CTL)-mediated immune pressure enriches NANOG(+)tumor cells with stem-like and immune-refractory properties that make them resistant to CTLs. Here, we report that the emergence of refractory phenotypes is highly associated with an aberrant macroautophagic/autophagic state of the NANOG(+)tumor cells and that the autophagic phenotype arises through transcriptional induction ofMAP1LC3B/LC3Bby NANOG. Furthermore, we found that upregulation of LC3B expression contributes to an increase in EGF secretion. The subsequent hyperactivation of EGFR-AKT signaling rendered NANOG(+)tumor cells resistant to CTL killing. The NANOG-LC3B-p-EGFR axis was preserved across various types of human cancer and correlated negatively with the overall survival of cervical cancer patients. Inhibition of LC3B in immune-refractory tumor models rendered tumors susceptible to adoptive T-cell transfer, as well as PDCD1/PD-1 blockade, and led to successful, long-term control of the disease. Thus, our findings demonstrate a novel link among immune-resistance, stem-like phenotypes, and LC3B-mediated autophagic secretion in immune-refractory tumor cells, and implicate the LC3B-p-EGFR axis as a central molecular target for controlling NANOG(+)immune-refractory cancer.